OrthoPediatrics (NASDAQ:KIDS) Shares Down 3.5% on Insider Selling

OrthoPediatrics Corp. (NASDAQ:KIDS) traded down 3.5% during trading on Wednesday following insider selling activity. The company traded as low as $24.48 and last traded at $24.54. 22,235 shares traded hands during trading, a decline of 86% from the average session volume of 162,242 shares. The stock had previously closed at $25.42.

Specifically, insider Gregory A. Odle sold 5,359 shares of the company’s stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total transaction of $133,224.74. Following the transaction, the insider now owns 148,788 shares in the company, valued at approximately $3,698,869.68. This represents a 3.48 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Fred Hite sold 6,443 shares of the company’s stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total value of $160,172.98. Following the transaction, the chief financial officer now owns 207,989 shares in the company, valued at $5,170,606.54. This trade represents a 3.00 % decrease in their position. The disclosure for this sale can be found here. In other OrthoPediatrics news, CEO David R. Bailey sold 6,620 shares of the company’s stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total transaction of $164,573.20. Following the transaction, the chief executive officer now owns 319,155 shares in the company, valued at approximately $7,934,193.30. This represents a 2.03 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the company. Needham & Company LLC restated a “buy” rating and issued a $42.00 price target on shares of OrthoPediatrics in a research note on Wednesday, March 5th. Stifel Nicolaus cut their price target on OrthoPediatrics from $40.00 to $32.00 and set a “buy” rating on the stock in a research note on Wednesday, March 5th. Finally, Truist Financial cut their price target on OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating on the stock in a research note on Wednesday, December 18th.

OrthoPediatrics Price Performance

The firm has a market capitalization of $620.29 million, a P/E ratio of -20.76 and a beta of 1.22. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17. The firm has a 50-day moving average of $24.84 and a 200-day moving average of $25.53.

OrthoPediatrics (NASDAQ:KIDS) last released its quarterly earnings data on Tuesday, March 4th. The company reported ($0.29) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.33) by $0.04. The business had revenue of $52.67 million for the quarter, compared to analysts’ expectations of $51.16 million. OrthoPediatrics had a negative return on equity of 5.78% and a negative net margin of 15.00%. During the same period in the prior year, the firm posted ($0.23) EPS. As a group, analysts predict that OrthoPediatrics Corp. will post -0.93 EPS for the current year.

Hedge Funds Weigh In On OrthoPediatrics

Hedge funds and other institutional investors have recently modified their holdings of the company. Wellington Management Group LLP lifted its holdings in shares of OrthoPediatrics by 16.2% during the 3rd quarter. Wellington Management Group LLP now owns 883,221 shares of the company’s stock valued at $23,944,000 after buying an additional 122,846 shares during the period. Barclays PLC lifted its holdings in shares of OrthoPediatrics by 319.3% during the 3rd quarter. Barclays PLC now owns 25,298 shares of the company’s stock valued at $686,000 after buying an additional 19,264 shares during the period. Geode Capital Management LLC lifted its holdings in shares of OrthoPediatrics by 2.1% during the 3rd quarter. Geode Capital Management LLC now owns 391,492 shares of the company’s stock valued at $10,615,000 after buying an additional 7,972 shares during the period. Mutual of America Capital Management LLC lifted its holdings in shares of OrthoPediatrics by 195.1% during the 3rd quarter. Mutual of America Capital Management LLC now owns 107,609 shares of the company’s stock valued at $2,917,000 after buying an additional 71,146 shares during the period. Finally, Centiva Capital LP bought a new position in shares of OrthoPediatrics during the 3rd quarter valued at $319,000. 69.05% of the stock is owned by institutional investors.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.